|
1
|
Enjolras O and Mulliken JB: Vascular
tumors and vascular malformation (new issuses). Adv Dermatol.
13:375–423. 1997.PubMed/NCBI
|
|
2
|
Mulliken J and Enjolras O: Congenital
hemangiomas and infantile hemangioma: missing links. J Am Acad
Dermatol. 50:875–882. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cahill AM and Nijs EL: Pediatric vascular
malformations: pathophysiology, diagnosis, and the role of
interventional radiology. Cardiovasc Intervent Radiol. 34:691–704.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Itinteang T, Tan ST, Guthrie S, Tan CE,
McIntyre BC, Brasch HD and Day DJ: A placental chorionic villous
mesenchymal core cellular origin for infantile haemangioma. J Clin
Pathol. 64:870–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Régnier S, Dupin N, Le Danff C, Wassef M,
Enjolras O and Aractingi S: Endothelial cells in infantile
haemangiomas originate from the child and not from the mother (a
fluorescence in situ hybridization-based study). Br J Dermatol.
157:158–160. 2007.PubMed/NCBI
|
|
6
|
Zhang GY, Yi CG, Li X, Liang ZQ, Wang RX,
Liu DE, Zhang LM, Meng CY and Guo SZ: Proliferation hemangiomas
formation through dual mechanism of vascular endothelial growth
factor mediated endothelial progenitor cells proliferation and
mobilization through matrix metalloproteinases 9. Med Hypotheses.
70:815–818. 2008. View Article : Google Scholar
|
|
7
|
Takahashi K, Mulliken JB, Kozakewich HP,
Rogers RA, Folkman J and Ezekowitz RA: Cellular markers that
distinguish the phases of hemangioma during infancy and childhood.
J Clin Invest. 93:2357–2364. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Peng Q, Matsuda T and Hirst SJ: Signaling
pathways regulating interleukin-13-stimulated chemokine release
from airway smooth muscle. Am J Respir Crit Care Med. 169:596–603.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Queto T, Vasconcelos ZF, Luz RA, et al:
G-CSF suppresses allergic pulmonary inflammation, downmodulating
cytokine, chemokine and eosinophil production. Life Sci.
88:830–838. 2011. View Article : Google Scholar
|
|
10
|
Gordillo GM, Onat D, Stockinger M, Roy S,
Atalay M, Beck FM and Sen CK: A key angiogenic role of monocyte
chemoattractant protein-l in hemangioendothelioma proliferation. Am
J Physiol Cell Physiol. 287:C866–C873. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Eum SY, Maghni K, Hamid Q, Eidelman DH,
Campbell H, Isogai S and Martin JG: Inhibition of allergic airways
inflammation and airway hyperresponsiveness in mice by
dexamethasone: role of eosinophils, IL-5, eotaxin, and IL-13. J
Allergy Clin Immunol. 111:1049–1061. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
North PE, Waner M, Mizeracki A and Mihm MC
Jr: GLUT-1: a newly discovered immunohistochemical marker for
juvenile hemangiomas. Hum Pathol. 31:11–22. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bauland CG, Smit JM, Bartelink LR,
Zondervan HA and Spauwen PH: Hemangioma in the newborn: increased
incidence after chorionic villus sampling. Prenat Diagn.
30:913–917. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Boye E, Yu Y, Paranya G, Mulliken JB,
Olsen BR and Bischoff J: Clonality and altered behavior of
endothelial cells from hemangiomas. J Clin Invest. 107:745–752.
2001. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Léauté-Labrèze C, Dumas de la Roque E,
Hubiche T, Boralevi F, Thambo JB and Taïeb A: Propanolol for severe
hemangiomas of infancy. N Engl J Med. 358:2649–2651. 2008.
|
|
16
|
Ji Y, Chen S, Li K, Xiao X, Zheng S and Xu
T: The role of β-adrenergic receptor signaling in the proliferation
of hemangioma-derived endothelial cells. Cell Div. 8:12013.
|
|
17
|
Ma G, Lin XX, Jin YB, et al: Isolation,
culture and identification of endothelial cells in infantile
hemangioma. Zhonghua Zheng Xing Wai Ke Za Zhi. 24:144–147. 2008.(In
Chinese).
|
|
18
|
Ma G, Lin XX, Jin YB, et al: Culture and
cryopreservation of endothelial cells in vitro in infantile
hemangioma. Zhonghua Zheng Xing Wai Ke Za Zhi. 24:197–200. 2008.(In
Chinese).
|
|
19
|
Bolognia JL, Jorizzo JL and Rapini RP:
Dermatology. 2nd Edition. Saunders (W.B) Co. Ltd; Philadelphia, PA,
USA: pp. 1905–1937. 2012
|
|
20
|
Léauté-Labrèze C, Prey S and Ezzedine K:
Infantile haemangioma: part I. Pathophysiology, epidemiology,
clinical features, life cycle and associated structural
abnormalities. J Eur Acad Dermatol Venereol. 25:1245–1253.
2011.PubMed/NCBI
|
|
21
|
Takahashi K, Mulliken JB, Kozakewich HP,
Rogers RA, Folkman J and Ezekowitz RA: Cellular markers that
distinguish the phases of hemangioma during infancy and childhood.
J Clin Invest. 93:2357–2364. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Sans V, de la Roque ED, Berge J, Grenier
N, et al: Propranolol for severe infantile hemangiomas: follow-up
report. Pediatrics. 124:e423–e431. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Sommers Smith SK and Smith DM: Beta
blockade induces apoptosis in cultured capillary endothelial cells.
In Vitro Cell Dev Biol Anim. 38:298–304. 2002.PubMed/NCBI
|
